MedPath

Cryotherapy in treatment of plantar wart Trichloroacetic acid 40% in treatment of plantar wart

Phase 3
Conditions
Plantar wart.
Cutaneous and mucocutaneous bartonellosis
Registration Number
IRCT20180212038696N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age range of 8-40 years
Non-pregnant
Activ safety
Non-smoker
Satisfaction with the Plan Contribution

Exclusion Criteria

Non

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
People who recognize their ''Plantar warts'' by dermatologist. Timepoint: After 14 days. Method of measurement: View lesions and register in the questionnaire.
Secondary Outcome Measures
NameTimeMethod
Improve lesions relative to initial condition. Timepoint: At the beginning of the study and every 14 days after the start of the treatment protocol. Method of measurement: Questionnaire contain 12 questions.
© Copyright 2025. All Rights Reserved by MedPath